Freefall, page-49

Just my opinion. OIL has a partner because it has a product worth partnering for. MSB has no partner because...

I read analysts reports on company's I invest in because sometimes I learn things I don't know but often I make different value judgements. However after looking at the material I found online aboout MSB I was surprised to find that Maquarie's view of the company was so similar to my own. This was some time ago, and from time to time I have checked on trials related to MSB's stem cell treatments, and so far nothing has impressed me as likely to stand up to critical scientific scrutiny, so I have never felt tempted to own the shares. The debut on the Nasdaq is better than I expected, but I feel sympathy for the investors who have lost money and I truly doubt it will ever come back.